95 filings
Page 4 of 5
6-K
56bg4lvfb5
7 Dec 20
Current report (foreign)
10:14am
6-K
hbcdlmadqhh3x6o2b
6 Nov 20
ERYTECH Announces Abstract with Results from Eryaspase
9:24am
6-K
u3l5wrjvv10xl 5s
3 Nov 20
ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French Government
4:33pm
6-K
xzgjhx0 k4f9
22 Sep 20
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020
12:00am
6-K
hy212a
21 Sep 20
I. Certification of the Person Responsible for the Half-year Financial Report
6:09am
6-K
vakmccwoqzs
15 Sep 20
ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment
7:32am
6-K
3pb4 zeb7c
26 Jun 20
Current report (foreign)
5:10pm
6-K
09iq27sfygyhu5 9u
25 Jun 20
Current report (foreign)
4:31pm
6-K
bte9oleerqgroep0h7
9 Jun 20
ERYTECH Provides Update on Phase 2 Investigator
4:11pm
6-K
keo6uqb lrobg
2 Jun 20
ERYTECH Announces Poster Presentations
5:07pm
6-K
3mcdj5zg3agff2
26 May 20
Erytech’s Combined Shareholders’ Meeting
4:40pm
6-K
g48owo9kv5oj8p
8 May 20
ERYTECH Provides Business Update and Reports Cash Balance at End of Q1 2020
4:08pm
6-K
k5cu4 cckbd
30 Apr 20
ERYTECH Granted U.S. FDA Fast Track Designation
7:59am
6-K
8m3ctuc pkb
21 Apr 20
ERYTECH Provides Update on theTRYbeCA-1
7:06am
6-K
z7x94tsi bt
17 Mar 20
ERYTECH Announces the Appointment of
4:25pm
6-K
r6ufco opveqqrxau51
6 Feb 20
Current report (foreign)
4:16pm
6-K
731rgkr2
8 Nov 19
ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of 2019
8:44am
6-K
x8e ejlaq22ja
26 Sep 19
Half-year Financial Report
4:14pm
6-K
xoftynh
18 Sep 19
Reports Financial Results for the First Half of 2019
9:30am
6-K
v3fcndf1nh1a549
16 Jul 19
ERYTECH Pharma Reports Voting Results from Annual
4:27pm